| Gene symbol | CD4 | Synonyms | CD4mut, IMD79, Leu-3, OKT4D, T4 | Type of gene | protein-coding | |
| Chromosome | 12 | Map location | 12p13.31 | dbXrefs | Entrez:920 MIM:186940 HGNC:HGNC:1678 Ensembl:ENSG00000010610 AllianceGenome:HGNC:1678 | |
| Description | CD4 molecule | |||||
| GTO ID | GTC3711 |
| Trial ID | NCT06197672 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD4 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD4 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory AML as a Bridge to Allogeneic Stem Cell Transplant |
| Year | 2024 |
| Country | United States |
| Company sponsor | Huda Salman |
| Other ID(s) | CTO-IUSCCC-0851 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||